- Home
- RLAY vs NP Comparison
RLAY vs NP Comparison
Compare RLAY & NP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLAY | NP |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.9B |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | RLAY | NP |
|---|---|---|
| Price | $18.41 | $27.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $27.58 | ★ $34.27 |
| AVG Volume (30 Days) | ★ 2.4M | 540.2K |
| Earning Date | 11-04-2026 | 10-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ 0.28 |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $29.12 |
| Revenue Next Year | $60.15 | $18.01 |
| P/E Ratio | ★ N/A | $102.21 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $5.95 | $14.78 |
| 52 Week High | $21.27 | $35.15 |
Technical Indicators
Market Signals| Indicator | RLAY | NP |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 39.26 |
| Support Level | $17.45 | $27.30 |
| Resistance Level | $20.31 | $29.54 |
| Average True Range (ATR) | 1.15 | 1.34 |
| MACD | -0.04 | -0.07 |
| Stochastic Oscillator | 44.29 | 26.98 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About NP Neptune Insurance Holdings Inc.
Neptune Insurance Holdings Inc is a high-growth, profitable, data-driven MGA that offers residential and commercial insurance products, including primary flood insurance, excess flood insurance and parametric earthquake insurance, distributed through a nationwide network of agencies in the United States. The company underwrites and administers the issuance of insurance policies on behalf of a diverse panel of insurance and reinsurance companies and does not take any balance sheet insurance risk or have claims handling responsibility relating to the policies it sells.